MK-0777

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameMK-0777
Drug Alias NameMK-0777TPA-023L-830982
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-3 agonistsGamma-aminobutyric acid A receptor alpha-2 agonists
TargetsGamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-3
Therapy Area/IndicationsSchizophreniaAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of PittsburghUniversity Of California, Los AngelesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsSchizophreniaAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A